Get notified when AKTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Material Weakness (worsened) — Material weaknesses now specifically identified as IT/QuickBooks controls and Purchase-to-Pay controls, providing more detail on scope than prior year's generic disclosure.
  • Goodwill Impairment (new) — Company recorded $8.4M goodwill impairment in Q1 2026 due to sustained market-cap decline.
  • Asset Impairment (new) — Company recorded $3.7M IPR&D asset impairment in Q1 2026 reflecting heightened uncertainty in advancing AKTX-101 under current capital constraints.
NASDAQ: AKTX Akari Therapeutics Plc 10-Q

AKTX posts $12M impairment on Peak Bio assets; control weaknesses persist into 2026

Filed May 19, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 14, 2025 · ~1 min read

Key Changes

  • high

    Company recorded $12.1M non-cash impairment ($8.4M goodwill, $3.7M IPR&D) in Q1 2026 triggered by sustained market-cap decline and heightened uncertainty in advancing AKTX-101 under capital constraints.

    MD&A: Impairment Charges verify on EDGAR →
  • high

    Material weaknesses in IT/QuickBooks and Purchase-to-Pay controls now explicitly identified; remediation commenced Q4 2025, three months later than originally planned Q3 2025 start.

    Controls and Procedures verify on EDGAR →
  • high

    Going-concern runway remains approximately 3-4 months from filing date (June 2026), despite $25M White Lion ELOC facility established August 2025 (no draws to date).

    MD&A: Liquidity verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade AKTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · May 26, 2026 · How we verify